CGS-CIMB Research

SPAC listings overall positive for SGX: CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

SPAC listings overall positive for SGX: CGS-CIMB

CGS-CIMB analyst Andrea Choong has kept "hold" on SGX with an unchanged target price of $10.70.
'Add' Yangzijiang as spinoff of debt investment portfolio will be re-rating catalyst: CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

'Add' Yangzijiang as spinoff of debt investment portfolio will be re-rating catalyst: CGS-CIMB

CGS-CIMB views the potential listing and Yangzijiang's ability to secure orders will drive its share price in the near term.
Outlook for semiconductor industry still strong heading into 2022: CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

Outlook for semiconductor industry still strong heading into 2022: CGS-CIMB

CGS-CIMB Research has an optimisic view of the semicon sector, giving "add" calls to all the companies it covers.

Broker's Calls

Aztech Global's current share price is 'opportunity' to enter, says CGS-CIMB

“Aztech’s performance has so far been in line with our expectations,” says CGS-CIMB analyst William Tng.
‘Storm is passing’ for CSE Global as it banks on energy order wins from Hurricane Ida - THE EDGE SINGAPORE

Broker's Calls

‘Storm is passing’ for CSE Global as it banks on energy order wins from Hurricane Ida

CGS-CIMB thinks CSE can find opportunities from the damage caused by Hurricane Ida, and remains optimistic on the stock.

Broker's Calls

CGS-CIMB lifts AEM Holdings' TP to $4.78 on initial success in customer diversification

The higher target price is due to the removal of the valuation discount that was previously pegged to AEM.
Singapore banks 'neutral' as impact of lifted dividend cap ends: CGS-CIMB  - THE EDGE SINGAPORE

Broker's Calls

Singapore banks 'neutral' as impact of lifted dividend cap ends: CGS-CIMB

"There is still ample liquidity in the system."
Analysts mixed on UG Healthcare as glove prices decline - THE EDGE SINGAPORE

Broker's Calls

Analysts mixed on UG Healthcare as glove prices decline

Analysts believe glove ASPs have peaked in 1Q21 and will decline in the near term as supply increases.
'Buy' IHH Healthcare as it enters next growth phase - THE EDGE SINGAPORE

Broker's Calls

'Buy' IHH Healthcare as it enters next growth phase

Of the brokerages, DBS and UOB Kay Hian have upped their estimates to $2.32 or RM7.20 and RM6.40 respectively.
Hong Leong Asia's 20% stake in BRC Asia brings greater collaboration: CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

Hong Leong Asia's 20% stake in BRC Asia brings greater collaboration: CGS-CIMB

"We are positive on this deal as we see synergistic collaboration between both parties."
×